Statins could protect the hearts of babies in the womb from the adverse effects of their mother’s stress, research suggests. Scientists have discovered that the widely-prescribed drugs help to counteract the negative impact of stress hormones on fetal growth and heart development in mice. The therapy could lower the chances of babies being born underweight [...]
As evidence builds on the risk for babies of overweight mothers, a new simple guide defines the right advice to follow. The current reality in the UK is that nearly 50 per cent of pregnant women attending their first maternity appointment are overweight (19 per cent) or obese (26 per cent). We also know that [...]
Children exposed to valproate in utero are at high risk of developmental disorders and congenital malformations. This week's Drug Safety Update from the MHRA signposts new communication materials for use by healthcare professionals. To further improve awareness of the risks of valproate in pregnancy MHRA are asking that you use the new communication materials to [...]
